Cargando…

CREBH regulation of lipid metabolism through multifaceted functions that improve arteriosclerosis

Cyclic adenosine monophosphate‐responsive element‐binding protein H (CREBH) activates lipoprotein lipase (LPL) activity by modulating apolipoproteins. Activated LPL hydrolyzes triglyceride‐rich lipoproteins, such as very low‐density lipoprotein (VLDL) and chylomicrons, resulting in remnant lipoprote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakagawa, Yoshimi, Matsuzaka, Takashi, Shimano, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248435/ https://www.ncbi.nlm.nih.gov/pubmed/35122696 http://dx.doi.org/10.1111/jdi.13766

Ejemplares similares

CREBH Regulates Systemic Glucose and Lipid Metabolism
por: Nakagawa, Yoshimi, et al.
Publicado: (2018)

CREBH Systemically Regulates Lipid Metabolism by Modulating and Integrating Cellular Functions
por: Nakagawa, Yoshimi, et al.
Publicado: (2021)

CREBH Improves Diet-Induced Obesity, Insulin Resistance, and Metabolic Disturbances by FGF21-Dependent and FGF21-Independent Mechanisms
por: Satoh, Aoi, et al.
Publicado: (2020)

Novel role for the CRTC2 in lipid homeostasis
por: Matsuzaka, Takashi, et al.
Publicado: (2016)

Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression
por: Kikuchi, Takuya, et al.
Publicado: (2016)

Rho‐associated, coiled‐coil‐containing protein kinase 1 as a new player in the regulation of hepatic lipogenesis
por: Miyamoto, Takafumi, et al.
Publicado: (2019)

CREBH Couples Circadian Clock With Hepatic Lipid Metabolism
por: Zheng, Ze, et al.
Publicado: (2016)

New liver–β‐cell axis that controls insulin secretory capacity
por: Matsuzaka, Takashi, et al.
Publicado: (2014)

GLUT12: a second insulin‐responsive glucose transporters as an emerging target for type 2 diabetes
por: Matsuzaka, Takashi, et al.
Publicado: (2011)

Insulin‐dependent and ‐independent regulation of sterol regulatory element‐binding protein‐1c
por: Matsuzaka, Takashi, et al.
Publicado: (2013)

The Influence of Hormones on Lipid Metabolism in Relation to Arteriosclerosis
por: Albrink, Margaret J.
Publicado: (1959)

Selective peroxisome proliferator‐activated receptor‐α modulator K‐877 efficiently activates the peroxisome proliferator‐activated receptor‐α pathway and improves lipid metabolism in mice
por: Takei, Kenta, et al.
Publicado: (2017)

CREBH Determines the Severity of Sulpyrine-Induced Fatal Shock
por: Kamiyama, Naganori, et al.
Publicado: (2013)

Molecular mechanisms involved in hepatic steatosis and insulin resistance
por: Matsuzaka, Takashi, et al.
Publicado: (2011)

New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
por: Matsuzaka, Takashi, et al.
Publicado: (2020)

Crucial Role of Elovl6 in Chondrocyte Growth and Differentiation during Growth Plate Development in Mice
por: Kikuchi, Manami, et al.
Publicado: (2016)

CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis
por: Park, Jong-Gil, et al.
Publicado: (2016)

Carrot Consumption Frequency Associated with Reduced BMI and Obesity through the SNP Intermediary rs4445711
por: Fujihara, Kazuya, et al.
Publicado: (2021)

Arteriosclerosis
Publicado: (1925)

Arteriosclerosis
Publicado: (1913)

Multifaceted regulation of hepatic lipid metabolism by YY1
por: Pan, Gang, et al.
Publicado: (2021)

Regulation of hepatic circadian metabolism by the E3 ubiquitin ligase HRD1-controlled CREBH/PPARα transcriptional program
por: Kim, Hyunbae, et al.
Publicado: (2021)

Ragulator—a multifaceted regulator of lysosomal signaling and trafficking
por: Colaço, Alexandria, et al.
Publicado: (2017)

Palmitate Impairs and Eicosapentaenoate Restores Insulin Secretion Through Regulation of SREBP-1c in Pancreatic Islets
por: Kato, Toyonori, et al.
Publicado: (2008)

EXPERIMENTAL ARTERIOSCLEROSIS
por: Pearce, Richard M., et al.
Publicado: (1906)

The Biology of Arteriosclerosis
por: Pappenheimer, Alwin M.
Publicado: (1938)

The Treatment of Arteriosclerosis
Publicado: (1906)

Arteriosclerosis and Diabetes
Publicado: (1925)

Antisclerosin in Arteriosclerosis
por: Goldschmidt, S.
Publicado: (1904)

Athletics and Arteriosclerosis
Publicado: (1904)

Treatment of Arteriosclerosis
Publicado: (1907)

Test for Arteriosclerosis
Publicado: (1914)

Predictive ability of current machine learning algorithms for type 2 diabetes mellitus: A meta‐analysis
por: Kodama, Satoru, et al.
Publicado: (2022)

Commentary: Retinal branch vein occlusion and arteriosclerosis: Can cardio-ankle vascular index be a useful biomarker?
por: Kaushal, Anshu, et al.
Publicado: (2020)

Cathepsin B overexpression induces degradation of perilipin 1 to cause lipid metabolism dysfunction in adipocytes
por: Mizunoe, Yuhei, et al.
Publicado: (2020)

The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice
por: Araki, Masaya, et al.
Publicado: (2018)

Association between Lysosomal Dysfunction and Obesity-Related Pathology: A Key Knowledge to Prevent Metabolic Syndrome
por: Mizunoe, Yuhei, et al.
Publicado: (2019)

Octacosanol and policosanol prevent high-fat diet-induced obesity and metabolic disorders by activating brown adipose tissue and improving liver metabolism
por: Sharma, Rahul, et al.
Publicado: (2019)

The clinical aspects of arteriosclerosis
por: Rinzler, Seymour H.
Publicado: (1957)

Sedentary behavior is associated with arteriosclerosis in frail older adults
por: Shiraishi, Nariaki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3st2nljvjo91caiipmbp227ccc